United States · Health Care · USD (Thousands) · Annual
Key financials
USD|Thousands
ROE
-125.15%
2025 (actual)
ROA
-106.21%
2025 (actual)
Gross Margin
64.28%
2025 (actual)
Net Margin
-
Total Assets
$24,742.58K
2025 (actual)
Net Income
-$46,895.94K
2025 (actual)
Valuation
$35,395.29K
2026 (forecast)
Stock Price
$5.07
Historical & projected performance
USD|Thousands
Reported figures and Equlion model projections for the next 5 years.
ROE
+152.7 pt
Company
Sector average (own scale)
ROA
-374.8 pt
Company
Gross Margin
-28.5 pt
Company
Sector average
Total Assets
-15.9%
Company
Sector average (own scale)
Net Income
-106.7%
Company
Valuation
+57.1%
Company
Stock Price
+57%
Company
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for Co-Diagnostics, Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.